Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
All of these work together to target skin health
In the current study, patients receiving ARA 290 appeared to improve specifically with respect to autonomic symptomatology, for example, with respect to dry eyes, blurred vision and orthostatic symptoms
McCarthy FO, Chopra J, Ford A et al (2005) Synthesis, isolation and characterisation of -sitosterol and -sitosterol oxide derivatives